載入...
Delivery of endostatin in experimental cancer therapy
Endostatin, the 20 kDa C-terminal fragment of collagen XVIII, has been shown to be an effective inhibitor of tumour angiogenesis and growth in different experimental systems and is currently in Phase II/III clinical trials. One challenging aspect of anti-angiogenic treatment is the mode of delivery...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Blackwell Science Inc
2002
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2517693/ https://ncbi.nlm.nih.gov/pubmed/12657135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2613.2002.00240.x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|